Published in Stroke on June 01, 1999
Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation. J Am Coll Cardiol (2008) 2.93
Death and disability from warfarin-associated intracranial and extracranial hemorrhages. Am J Med (2007) 2.16
Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study. Circulation (2005) 1.66
Assessment of female sex as a risk factor in atrial fibrillation in Sweden: nationwide retrospective cohort study. BMJ (2012) 1.61
Statin use is associated with lower risk of atrial fibrillation in women with coronary disease: the HERS trial. Heart (2009) 1.54
Anticoagulation therapy for patients with atrial fibrillation. CMAJ (2000) 1.42
Sex differences in stroke. Cerebrovasc Dis (2008) 1.24
Warfarin in atrial fibrillation patients with moderate chronic kidney disease. Clin J Am Soc Nephrol (2011) 1.15
Thrombosis and antithrombotic therapy in women. Arterioscler Thromb Vasc Biol (2009) 1.03
Sex-specific responses to stroke. Future Neurol (2010) 0.96
New insights into the mechanisms and management of atrial fibrillation. CMAJ (2002) 0.96
Atrial fibrillation, stroke, and anticoagulation in Medicare beneficiaries: trends by age, sex, and race, 1992-2010. J Am Heart Assoc (2014) 0.92
Safe use of antithrombotics for stroke prevention in atrial fibrillation: consideration of risk assessment tools to support decision-making. Ther Adv Drug Saf (2014) 0.89
Atrial fibrillation: challenges and opportunities. Can J Cardiol (2006) 0.87
Role of oral anticoagulation in management of atrial fibrillation. Heart (2004) 0.87
Sex-related predictors for thromboembolic events after catheter ablation of atrial fibrillation: The Leipzig Heart Center AF Ablation Registry. Clin Res Cardiol (2015) 0.86
Estrogen and neuroprotection: from clinical observations to molecular mechanisms. Dialogues Clin Neurosci (2002) 0.86
Critical pathways for post-emergency outpatient diagnosis and treatment: tools to improve the value of emergency care. Acad Emerg Med (2011) 0.83
Atrial fibrillation and heart failure in the elderly. Heart Fail Rev (2012) 0.83
Clinical epidemiology of atrial fibrillation and related cerebrovascular events in the United States. Neurologist (2008) 0.83
Assessment of CHADS2 and CHA 2DS 2-VASc scores in obstructive sleep apnea patients with atrial fibrillation. Sleep Breath (2014) 0.82
Does CHA2DS2-VASc improve stroke risk stratification in postmenopausal women with atrial fibrillation? Am J Med (2013) 0.79
Cardioembolic stroke in atrial fibrillation-rationale for preventive closure of the left atrial appendage. Korean Circ J (2009) 0.79
Atrial fibrillation and thromboprophylaxis in heart failure: the need for patient-centered approaches to address adherence. Vasc Health Risk Manag (2013) 0.79
Significance of cardiac sympathetic nervous system abnormality for predicting vascular events in patients with idiopathic paroxysmal atrial fibrillation. Eur J Nucl Med Mol Imaging (2009) 0.78
Stroke in women. Nutr Metab Cardiovasc Dis (2010) 0.78
Efficacy and Safety of Edoxaban in Elderly Patients With Atrial Fibrillation in the ENGAGE AF-TIMI 48 Trial. J Am Heart Assoc (2016) 0.78
Antithrombotic therapy for the treatment of atrial fibrillation in the elderly. J Interv Card Electrophysiol (2009) 0.77
Field Synopsis of the Role of Sex in Stroke Prediction Models. J Am Heart Assoc (2016) 0.77
Epidemiology, diagnosis, and management of atrial fibrillation in women. Int J Womens Health (2015) 0.77
Atrial fibrillation in heart failure: stroke risk stratification and anticoagulation. Heart Fail Rev (2014) 0.76
The use of antithrombotics in patients presenting with stroke and atrial fibrillation. Ther Clin Risk Manag (2007) 0.76
Stroke with atrial fibrillation or atrial flutter: a descriptive population-based study from the Brest stroke registry. BMC Geriatr (2015) 0.75
Atrial fibrillation in older patients-reducing stroke risk is not only about anticoagulation. J Geriatr Cardiol (2016) 0.75
The Connection between Cardiac and Mental Disorder: Atrial Fibrillation in Patients with Psychiatric Disorder. Zhonghua Minguo Xin Zang Xue Hui Za Zhi (2014) 0.75
Sex- and gender-specific research priorities for the emergency management of heart failure and acute arrhythmia: proceedings from the 2014 Academic Emergency Medicine Consensus Conference Cardiovascular Research Workgroup. Acad Emerg Med (2014) 0.75
Clinical characteristics and impact of diabetes mellitus on outcomes in patients with nonvalvular atrial fibrillation. Yonsei Med J (2015) 0.75
Atrial fibrillation: relation between clinical risk factors and transoesophageal echocardiographic risk factors for thromboembolism. Heart (2003) 0.75
Risk of stroke and heart failure attributable to atrial fibrillation in middle-aged and elderly people: Results from a five-year prospective cohort study of Japanese community dwellers. J Epidemiol (2017) 0.75
Atrial Fibrillation: Epidemiology, Pathophysiology, and Clinical Outcomes. Circ Res (2017) 0.75
Sex Differences in Outcomes among Stroke Survivors with Non-Valvular Atrial Fibrillation in China. Front Neurol (2017) 0.75
Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis. Ann Intern Med (1999) 7.74
Use of transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation. N Engl J Med (2001) 5.67
Blood-pressure targets in patients with recent lacunar stroke: the SPS3 randomised trial. Lancet (2013) 5.20
Stroke with intermittent atrial fibrillation: incidence and predictors during aspirin therapy. Stroke Prevention in Atrial Fibrillation Investigators. J Am Coll Cardiol (2000) 3.36
Incidence of left-ventricular thrombosis after acute transmural myocardial infarction. Serial evaluation by two-dimensional echocardiography. N Engl J Med (1981) 3.00
Left atrial diameter in nonvalvular atrial fibrillation: An echocardiographic study. Stroke Prevention in Atrial Fibrillation Investigators. Am Heart J (1999) 2.68
Transesophageal echocardiographic correlates of clinical risk of thromboembolism in nonvalvular atrial fibrillation. Stroke Prevention in Atrial Fibrillation III Investigators. J Am Coll Cardiol (1998) 1.95
Occurrence of hemispheric and retinal ischemia in atrial fibrillation compared with carotid stenosis. Stroke (2002) 1.61
Observations on detecting left ventricular thrombus with two dimensional echocardiography: emphasis on avoidance of false positive diagnoses. Am J Cardiol (1981) 1.60
Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators. J Am Coll Cardiol (1992) 1.55
Separating favorable from unfavorable prognostic markers in breast cancer: the role of E-cadherin. Cancer Res (2000) 1.55
The prevalence of cardiac valvular insufficiency assessed by transthoracic echocardiography in obese patients treated with appetite-suppressant drugs. N Engl J Med (1998) 1.51
Aspirin for the primary prevention of stroke and other major vascular events: meta-analysis and hypotheses. Arch Neurol (2000) 1.49
Embolic potential of left ventricular thrombi detected by two-dimensional echocardiography. Circulation (1984) 1.44
Comparison of outcome of asymptomatic to symptomatic patients older than 20 years of age with valvular aortic stenosis. Am J Cardiol (1988) 1.43
Two-dimensional echocardiographic imaging of left ventricular mural vegetations. Am Heart J (1988) 1.42
Prospective evaluation of factors associated with intraaortic balloon rupture. ASAIO J (1996) 1.39
Cardioembolic vs. noncardioembolic strokes in atrial fibrillation: frequency and effect of antithrombotic agents in the stroke prevention in atrial fibrillation studies. Cerebrovasc Dis (2000) 1.37
Oral anticoagulants versus antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no history of stroke or transient ischemic attacks. Cochrane Database Syst Rev (2007) 1.33
Recurrent brain hemorrhage is more frequent than ischemic stroke after intracranial hemorrhage. Neurology (2001) 1.33
Progressive myoclonus epilepsy with Lafora inclusion bodies. I. Clinical, genetic, histopathologic, and biochemical aspects. Arch Neurol (1967) 1.32
Clinical and echocardiographic features of intermittent atrial fibrillation that predict recurrent atrial fibrillation. Stroke Prevention in Atrial Fibrillation (SPAF) Investigators. Am J Cardiol (1995) 1.31
Design of clinical database management systems and associated software to facilitate medical statistical research. Crit Rev Med Inform (1988) 1.30
Pathophysiologic correlates of thromboembolism in nonvalvular atrial fibrillation: I. Reduced flow velocity in the left atrial appendage (The Stroke Prevention in Atrial Fibrillation [SPAF-III] study). J Am Soc Echocardiogr (1999) 1.22
Single vs. double data entry in CAST. Control Clin Trials (1992) 1.21
Suppression of ventricular ectopic depolarizations by flecainide acetate, a new antiarrhythmic agent. Circulation (1982) 1.20
Significant pelvic recurrence in high-risk pathologic stage I--IV endometrial carcinoma patients after adjuvant chemotherapy alone: implications for adjuvant radiation therapy. Int J Radiat Oncol Biol Phys (2001) 1.12
Familial hypokalemic periodic paralysis with permanent myopathy. A clinical and ultrastructural study. J Neuropathol Exp Neurol (1967) 1.07
Single-chain Fv fragments of anti-neuraminidase antibody NC10 containing five- and ten-residue linkers form dimers and with zero-residue linker a trimer. Protein Eng (1997) 1.07
Primary prevention studies and the healthy elderly: evaluating barriers to recruitment. J Community Health (2000) 1.06
Conceptus-induced changes in the endometrial transcriptome: how soon does the cow know she is pregnant? Biol Reprod (2011) 1.04
Tympanic membrane thermometry in the care of out-of-hospital patients. Ann Emerg Med (1995) 1.02
Variability in chemotherapy delivery for elderly women with advanced stage ovarian cancer and its impact on survival. Br J Cancer (2008) 1.01
Two-dimensional echocardiographic identification of left ventricular pseudoaneurysm. Am Heart J (1986) 1.01
Two-dimensional echocardiographic demonstration of left atrial thrombi in patients with prosthetic mitral valves. Circulation (1979) 1.00
Indications for echocardiography in patients with ischemic stroke. Neurology (1982) 0.99
Smoking in patients with panic disorder. Psychiatry Res (1992) 0.99
Sex and other predictors of intra-aortic balloon counterpulsation-related complications: prospective study of 1119 consecutive patients. Am Heart J (2000) 0.99
Familial spinocerebellar degeneration, hemolytic anemia, and glutathione deficiency. Arch Intern Med (1974) 0.98
Right versus left prefrontal transcranial magnetic stimulation for obsessive-compulsive disorder: a preliminary investigation. J Clin Psychiatry (2001) 0.97
Mitral regurgitation associated with reduced thromboembolic events in high-risk patients with nonrheumatic atrial fibrillation. Stroke Prevention in Atrial Fibrillation Investigators. Am J Cardiol (1993) 0.97
Regional stasis of blood in the dysfunctional left ventricle: echocardiographic detection and differentiation from early thrombosis. Circulation (1982) 0.97
Progressive myoclonus epilepsy with Lafora inclusion bodies. II. Studies of ultrastructure. Arch Neurol (1967) 0.97
Carotid stenosis in patients with atrial fibrillation. Prevalence, risk factors, and relationship to stroke in the Stroke Prevention in Atrial Fibrillation Study. Arch Intern Med (1994) 0.96
Reactive oxygen species may cause myocardial reperfusion injury. Biochem Biophys Res Commun (1985) 0.95
Antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks. Cochrane Database Syst Rev (2000) 0.95
Age and clinical immunity to infections with Chlamydia trachomatis. Sex Transm Dis (1994) 0.95
Two-dimensional echocardiographic identification of complicated aortic root endocarditis: implications for surgery. J Am Coll Cardiol (1987) 0.95
Epidemiologic features of asymptomatic cerebral infarction in patients with nonvalvular atrial fibrillation. Arch Intern Med (1990) 0.94
Echocardiography in diagnostic assessment of stroke. Ann Intern Med (1981) 0.92
Histamine and spermidine content in brain during development. Science (1969) 0.92
Frequency of hypokalemia after successfully resuscitated out-of-hospital cardiac arrest compared with that in transmural acute myocardial infarction. Am J Cardiol (1987) 0.91
Toward vital status sweeps: a case history in sequential monitoring. Stat Med (1995) 0.91
Amantadine for Parkinson's disease. Neurology (1971) 0.90
Progesterone-regulated changes in endometrial gene expression contribute to advanced conceptus development in cattle. Biol Reprod (2009) 0.90
Aortic plaque in atrial fibrillation: prevalence, predictors, and thromboembolic implications. Stroke (1999) 0.89
Pathophysiologic correlates of thromboembolism in nonvalvular atrial fibrillation: II. Dense spontaneous echocardiographic contrast (The Stroke Prevention in Atrial Fibrillation [SPAF-III] study). J Am Soc Echocardiogr (1999) 0.88
Alcohol-induced congestive cardiomyopathy: an animal model. Cardiovasc Res (1983) 0.88
Biochemical markers of alcohol abuse. QJM (1996) 0.87
Association of varicella, myocarditis, and congestive cardiomyopathy. Pediatr Cardiol (1982) 0.86
Juvenile amaurotic idiocy. An electon microscopic study. Neurology (1966) 0.85
Ischemic stroke in patients with atrial fibrillation: effect of aspirin according to stroke mechanism. Stroke Prevention in Atrial Fibrillation Investigators. Neurology (1993) 0.85
Expression in Escherichia coli of the putative N-acetylneuraminate lyase gene (nanA) from Haemophilus influenzae: overproduction, purification, and crystallization. Protein Expr Purif (1998) 0.84
Tissue acoustic properties of fresh left ventricular thrombi and visualization by two dimensional echocardiography: experimental observations. Am J Cardiol (1982) 0.84
Separation and identification of neutral and acidic metabolites in cerebrospinal fluid. Clin Chem (1972) 0.84
Effects of congestive heart failure on plasma von Willebrand factor and soluble P-selectin concentrations in patients with non-valvar atrial fibrillation. Heart (2005) 0.83
Increased risk of intracranial hemorrhage when aspirin is combined with warfarin: A meta-analysis and hypothesis. Cerebrovasc Dis (1999) 0.83
Differential effect of aspirin versus warfarin on clinical stroke types in patients with atrial fibrillation. Stroke Prevention in Atrial Fibrillation Investigators. Neurology (1996) 0.83
Motivation of subjects to participate in a research trial. Appl Nurs Res (1992) 0.83
Pirbuterol: a new oral sympathomimetic amine for the treatment of congestive heart failure. Am Heart J (1981) 0.83
A survey of clinical trial coordinators: factors influencing job satisfaction and turnover. Cardiovasc Nurs (1995) 0.82
Left ventricular function during spontaneous angina pectoris: effect of sublingual nitroglycerin. Am J Cardiol (1980) 0.81
Acute coronary syndromes in the United States and United Kingdom: a comparison of approaches. The Antithrombotic Therapy in Acute Coronary Syndromes Research Group. Clin Cardiol (1998) 0.81
Parameters of temporal recovery of the human auditory evoked potential. Electroencephalogr Clin Neurophysiol (1976) 0.80
Prospective comparison of unstable angina versus non-Q wave myocardial infarction during antithrombotic therapy. Antithrombotic Therapy in Acute Coronary Syndromes Research Group. J Am Coll Cardiol (1993) 0.80
Body fluid spaces and blood pressure in hemodialysis patients during amelioration of anemia with erythropoietin. Am J Kidney Dis (1990) 0.80
Mesothelioma of the AV node: potential utility of pacing. Pacing Clin Electrophysiol (1988) 0.80
Fatal cardiac arrest during continuous ambulatory monitoring. N Engl J Med (1981) 0.79
Functional consequences of interventricular septal involvement in right ventricular infarction: echocardiographic, clinical, and hemodynamic observations. Am Heart J (1983) 0.79
Propranolol antagonism of phenylpropanolamine-induced hypertension. Clin Pharmacol Ther (1985) 0.79
Oral anticoagulants for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks. Cochrane Database Syst Rev (2000) 0.79
Plasmin-alpha2-antiplasmin complex in patients with atrial fibrillation. Stroke Prevention in Atrial Fibrillation Investigators. Thromb Haemost (1999) 0.79